NCT03348891 2026-04-14
MELANFα
Institut Claudius Regaud
Phase NA Completed
Clinical Trials
15 trialsNCT02133222 2026-03-31
AMMAM
Centre Hospitalier Universitaire de Nice
Phase NA Completed
NCT07422805 2026-02-24
ctDNA
Institute of Oncology Ljubljana
Phase NA Completed
NCT03225365 2025-09-17
IMMUNONIVO
Hospices Civils de Lyon
Phase NA Completed
NCT02626065 2025-09-15
PAIR
Hospices Civils de Lyon
Phase 4 Completed
NCT02831634 2025-09-08
NeoEpitope
Institut Curie
Phase NA Completed
NCT02278887 2025-03-10
TIL
The Netherlands Cancer Institute
Phase 3 Completed
NCT03267381 2023-12-14
Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy
Vanderbilt-Ingram Cancer Center
Completed
NCT03416933 2023-08-04
OPTIMEL
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT05817149 2023-04-18
Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study
Aalborg University Hospital
Completed
NCT02907086 2022-06-06
Circulating Tumor Material in Colorectal Cancer and Melanoma
Abramson Cancer Center at Penn Medicine
Completed
NCT04154163 2022-02-28
ADOPT
University of Dundee
Completed
NCT01916135 2020-04-27
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01528774 2017-07-26
CTC
Comprehensive Cancer Centers of Nevada
Completed
NCT00615095 2011-04-20
Differential Risks for Melanoma: p16 and DNA Repair
Memorial Sloan Kettering Cancer Center
Completed